CLONIT SRL of Siziano at MEDICA 2022 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option


Via Lombardia 6, 27010 Siziano
Telephone +39-02-56814413
Fax +39-02-56814515

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2022 hall map (Hall 3): stand C60

Fairground map

MEDICA 2022 fairground map: Hall 3


Dario Russo

Managing Director

Iuri Aguzzi

International Sales Manager

Angela Cardin

Marketing Manager

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Company news



20 Jun 2022

New Oncohematology products

Clonit, Innovation and Passion to serve Acute myeloid leukemia (AML) diagnosis and monitoring.

We are pleased to announce the recent introduction of the new Oncohematology line of products in our catalogue.
In the last months our R&D department has been deeply engaged in studying and developing three new specific molecular assays that can help the diagnosis of Leukemia. 
The three kits PML-RARA t(15;17)(q22;q21), AML1-ETO t(8;21)(q22;q22) and Inv(16)(p13q22) - CBFB-MYH11, belonging to the new Clonit's Oncohematology line, have been designed following the "Europe Against Cancer (EAC) Guidelines - Leukemia 2003" and they are CE IVD marked according to the IVDD 98/79 CE.
The new molecular assays are based on a one-step Real-Time RT-PCR protocol starting from peripheral blood or bone marrow samples and can be performed on the most common Real-Time PCR Systems.
qRT- PCR shows significant sensitivity in the detection of the translocations or chromosomal abnormalities in patients with Acute myeloid leukemia (AML). Toghether with the cytogenetic analysis it represents an important tool in the screening of acute leukemia patients and should provide useful information for the diagnosis and prognosis even in situations with low patient material and allows patients to be assigned to the appropriate risk group for management and therapy.
Thanks to our passion for health and for a better life, combined with our strong expertise in molecular biology, we are giving our contribution to AML diagnosis and monitoring, helping patients and clinicians fighting AML.

This makes us proud and happy!

Stay tuned on upcoming Clonit innovation news!

More Less

About us

Company portrait

Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics.

A deep expertise in Molecular Biology mixed to our strong culture of business ethics make our company a valued partner for laboratories and hospitals around the world.

With our high standard and high performance IVDs portfolio, we aim to improve healthcare by enhancing and supporting the decision-making process, in line with scientific and technological evolution.

Our clinical diagnostic products are used to detect a broad range of diseases in several key areas such as viral, bacterial and fungal infections (including sexually transmitted diseases, transplantation/immunocompromised related infections, tropical diseases, healthcare associated infections), thrombophilia, oncohematology and several genetic disorders.

The standardization of internal quality control system and cross-checks in external reference labs allow Clonit to ensure application of the highest standards of care and quality (ISO 9001 and ISO 13485 Certified). Recently Clonit obtained the certification of products according to EU 2017/746 Regulation on In Vitro Diagnostic Medical Devices (IVDR). Certification for Class C products was issued by TÜV SÜD Product Service 

The company is registered and authorized by the Italian Ministry of the Health for the development, manufacturing and commercialization of Medical Diagnostic devices.

We listen carefully to our customers’ needs and work closely with health care professionals to transform them into solutions that provide people a better quality of life.